(Q34296389)

1 August 2017

Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer (English)

1 reference

1 August 2017

Min Shi

1

1 reference

1 August 2017

Weizhen Huang

2

1 reference

1 August 2017

Li Lin

3

1 reference

1 August 2017

Dayong Zheng

4

1 reference

1 August 2017

Qiang Zuo

5

1 reference

1 August 2017

Lin Wang

6

1 reference

1 August 2017

Nina Wang

7

1 reference

1 August 2017

Yajun Wu

8

1 reference

1 August 2017

Yulin Liao

9

1 reference

1 August 2017

Wangjun Liao

10

1 reference

1 August 2017

language of work or name

English

0 references

publication date

23 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

7

1 reference

1 August 2017

8

1 reference

1 August 2017

e41660

1 reference

Creative Commons Attribution 4.0 International

1 August 2017

start time

23 August 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Phosphatidylinositol 3-kinase-binding protein, PI3KAP/XB130, is required for cAMP-induced amplification of IGF mitogenic activity in FRTL-5 thyroid cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

Roles of XB130, a novel adaptor protein, in cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

XB130, a novel adaptor protein, promotes thyroid tumor growth

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

Adaptor protein XB130 is a Rac-controlled component of lamellipodia that regulates cell motility and invasion.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

E-cadherin adhesion activates c-Src signaling at cell-cell contacts

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

XB130, a novel adaptor protein for signal transduction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

Epidermal growth factor-regulated activation of Rac GTPase enhances CD44 cleavage by metalloproteinase disintegrin ADAM10.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

ErbA: tumor suppressor turned oncogene?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

The paradox of E2F1: oncogene and tumor suppressor gene.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426513

Irinotecan is inactive as a first-line treatment, but plays an important part in gastric cancer treatment

28 October 2018

1 reference

12 December 2020

Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins

1 reference

12 December 2020

p53 and Ki-67 expression in epithelial gastric dysplasia and in gastric cancer

1 reference

12 December 2020

p27: tumor suppressor and oncogene ...?

1 reference

12 December 2020

Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0041660

Identifiers

DOI

1 reference

1 August 2017

0 references

1 reference

1 August 2017

1 reference